Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-01-05 @ 5:34 PM
Study NCT ID:
NCT05393869
Status:
COMPLETED
Last Update Posted:
2023-12-26
First Post:
2022-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'interventionBrowseModule': {'meshes': [{'id': 'D058015', 'term': 'Health Communication'}], 'ancestors': [{'id': 'D005159', 'term': 'Health Care Facilities Workforce and Services'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'patterson.1191@osu.edu', 'phone': '614-247-1780', 'title': 'Dr. Joanne G. Patterson', 'organization': 'The Ohio State University College of Public Health'}, 'certainAgreement': {'piSponsorEmployee': True, 'restrictiveAgreement': False}}, 'adverseEventsModule': {'timeFrame': '1 hour post-baseline', 'eventGroups': [{'id': 'EG000', 'title': 'AR-Quit', 'description': 'Participants view messages with absolute risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.', 'otherNumAtRisk': 407, 'deathsNumAtRisk': 407, 'otherNumAffected': 0, 'seriousNumAtRisk': 407, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'AR-Switch', 'description': 'Participants view messages with absolute risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.', 'otherNumAtRisk': 407, 'deathsNumAtRisk': 407, 'otherNumAffected': 0, 'seriousNumAtRisk': 407, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG002', 'title': 'AR-Combination', 'description': 'Participants view messages with absolute risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.', 'otherNumAtRisk': 407, 'deathsNumAtRisk': 407, 'otherNumAffected': 0, 'seriousNumAtRisk': 407, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG003', 'title': 'RR-Quit', 'description': 'Participants view messages with comparative risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.', 'otherNumAtRisk': 407, 'deathsNumAtRisk': 407, 'otherNumAffected': 0, 'seriousNumAtRisk': 407, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG004', 'title': 'RR-Switch', 'description': 'Participants view messages with comparative risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.', 'otherNumAtRisk': 407, 'deathsNumAtRisk': 407, 'otherNumAffected': 0, 'seriousNumAtRisk': 407, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG005', 'title': 'RR-Combination', 'description': 'Participants view messages with comparative risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.', 'otherNumAtRisk': 407, 'deathsNumAtRisk': 407, 'otherNumAffected': 0, 'seriousNumAtRisk': 407, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG006', 'title': 'Control', 'description': 'Participants view FDA regulatory messages\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.', 'otherNumAtRisk': 407, 'deathsNumAtRisk': 407, 'otherNumAffected': 0, 'seriousNumAtRisk': 407, 'deathsNumAffected': 0, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Message Perceived Effectiveness - Persuasive Potential.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '399', 'groupId': 'OG000'}, {'value': '402', 'groupId': 'OG001'}, {'value': '396', 'groupId': 'OG002'}, {'value': '403', 'groupId': 'OG003'}, {'value': '401', 'groupId': 'OG004'}, {'value': '402', 'groupId': 'OG005'}, {'value': '402', 'groupId': 'OG006'}]}], 'groups': [{'id': 'OG000', 'title': 'AR-Quit', 'description': 'Participants view messages with absolute risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG001', 'title': 'AR-Switch', 'description': 'Participants view messages with absolute risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG002', 'title': 'AR-Combination', 'description': 'Participants view messages with absolute risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG003', 'title': 'RR-Quit', 'description': 'Participants view messages with comparative risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG004', 'title': 'RR-Switch', 'description': 'Participants view messages with comparative risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG005', 'title': 'RR-Combination', 'description': 'Participants view messages with comparative risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG006', 'title': 'Control', 'description': 'Participants view FDA regulatory messages\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}], 'classes': [{'categories': [{'measurements': [{'value': '3.57', 'groupId': 'OG000', 'lowerLimit': '3.47', 'upperLimit': '3.67'}, {'value': '3.24', 'groupId': 'OG001', 'lowerLimit': '3.13', 'upperLimit': '3.35'}, {'value': '3.26', 'groupId': 'OG002', 'lowerLimit': '3.15', 'upperLimit': '3.36'}, {'value': '3.44', 'groupId': 'OG003', 'lowerLimit': '3.33', 'upperLimit': '3.54'}, {'value': '2.93', 'groupId': 'OG004', 'lowerLimit': '2.42', 'upperLimit': '3.44'}, {'value': '2.98', 'groupId': 'OG005', 'lowerLimit': '2.48', 'upperLimit': '3.49'}, {'value': '3.10', 'groupId': 'OG006', 'lowerLimit': '2.96', 'upperLimit': '3.24'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Immediately post-exposure to intervention, up to 1 hour', 'description': '6 items measured on 5-point scale, 1 = Not at all and 5 = Very much\n\n* These messages were worth remembering.\n* These messages grabbed my attention.\n* These messages are powerful.\n* These messages are convincing.\n* These messages are meaningful.\n* These messages are informative.\n\nResponses were summed and averaged to create a scale for intention to quit (range from 1 - 5).\n\nHigher scores indicate a higher persuasive potential of the message.', 'unitOfMeasure': 'units on a scale', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Analytic population only included participants who had no missing data for any scale items.'}, {'type': 'PRIMARY', 'title': 'Perceived Effectiveness - Perceived Behavioral Impact', 'denoms': [{'units': 'Participants', 'counts': [{'value': '403', 'groupId': 'OG000'}, {'value': '407', 'groupId': 'OG001'}, {'value': '399', 'groupId': 'OG002'}, {'value': '405', 'groupId': 'OG003'}, {'value': '403', 'groupId': 'OG004'}, {'value': '405', 'groupId': 'OG005'}, {'value': '405', 'groupId': 'OG006'}]}], 'groups': [{'id': 'OG000', 'title': 'AR-Quit', 'description': 'Participants view messages with absolute risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG001', 'title': 'AR-Switch', 'description': 'Participants view messages with absolute risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG002', 'title': 'AR-Combination', 'description': 'Participants view messages with absolute risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG003', 'title': 'RR-Quit', 'description': 'Participants view messages with comparative risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG004', 'title': 'RR-Switch', 'description': 'Participants view messages with comparative risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG005', 'title': 'RR-Combination', 'description': 'Participants view messages with comparative risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG006', 'title': 'Control', 'description': 'Participants view FDA regulatory messages\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}], 'classes': [{'title': 'These messages will motivate people to quit ALL smoking and vaping.', 'categories': [{'measurements': [{'value': '2.96', 'groupId': 'OG000', 'lowerLimit': '2.84', 'upperLimit': '3.08'}, {'value': '2.38', 'groupId': 'OG001', 'lowerLimit': '2.25', 'upperLimit': '2.50'}, {'value': '2.44', 'groupId': 'OG002', 'lowerLimit': '2.32', 'upperLimit': '2.56'}, {'value': '2.71', 'groupId': 'OG003', 'lowerLimit': '2.59', 'upperLimit': '2.84'}, {'value': '2.07', 'groupId': 'OG004', 'lowerLimit': '1.96', 'upperLimit': '2.19'}, {'value': '2.22', 'groupId': 'OG005', 'lowerLimit': '2.11', 'upperLimit': '2.34'}, {'value': '2.76', 'groupId': 'OG006', 'lowerLimit': '2.63', 'upperLimit': '2.88'}]}]}, {'title': 'These messages will motivate CIGARETTE SMOKERS to quit.', 'categories': [{'measurements': [{'value': '3.11', 'groupId': 'OG000', 'lowerLimit': '2.97', 'upperLimit': '3.23'}, {'value': '3.10', 'groupId': 'OG001', 'lowerLimit': '2.98', 'upperLimit': '3.22'}, {'value': '3.16', 'groupId': 'OG002', 'lowerLimit': '3.04', 'upperLimit': '3.27'}, {'value': '3.28', 'groupId': 'OG003', 'lowerLimit': '3.17', 'upperLimit': '3.40'}, {'value': '3.00', 'groupId': 'OG004', 'lowerLimit': '2.88', 'upperLimit': '3.11'}, {'value': '3.17', 'groupId': 'OG005', 'lowerLimit': '3.04', 'upperLimit': '3.29'}, {'value': '2.82', 'groupId': 'OG006', 'lowerLimit': '2.70', 'upperLimit': '2.95'}]}]}, {'title': 'These messages will motivate CIGARETTE SMOKERS to switch to vaping', 'categories': [{'measurements': [{'value': '2.10', 'groupId': 'OG000', 'lowerLimit': '2.00', 'upperLimit': '2.21'}, {'value': '3.52', 'groupId': 'OG001', 'lowerLimit': '3.40', 'upperLimit': '3.63'}, {'value': '3.41', 'groupId': 'OG002', 'lowerLimit': '3.29', 'upperLimit': '3.53'}, {'value': '3.34', 'groupId': 'OG003', 'lowerLimit': '3.22', 'upperLimit': '3.45'}, {'value': '3.67', 'groupId': 'OG004', 'lowerLimit': '3.57', 'upperLimit': '3.78'}, {'value': '3.67', 'groupId': 'OG005', 'lowerLimit': '3.56', 'upperLimit': '3.78'}, {'value': '1.81', 'groupId': 'OG006', 'lowerLimit': '1.72', 'upperLimit': '1.91'}]}]}, {'title': 'These messages will motivate VAPERS to quit.', 'categories': [{'measurements': [{'value': '2.96', 'groupId': 'OG000', 'lowerLimit': '2.84', 'upperLimit': '3.08'}, {'value': '2.21', 'groupId': 'OG001', 'lowerLimit': '2.09', 'upperLimit': '2.33'}, {'value': '2.26', 'groupId': 'OG002', 'lowerLimit': '2.14', 'upperLimit': '2.37'}, {'value': '2.53', 'groupId': 'OG003', 'lowerLimit': '2.41', 'upperLimit': '2.64'}, {'value': '1.84', 'groupId': 'OG004', 'lowerLimit': '1.73', 'upperLimit': '1.94'}, {'value': '1.94', 'groupId': 'OG005', 'lowerLimit': '1.83', 'upperLimit': '2.04'}, {'value': '2.83', 'groupId': 'OG006', 'lowerLimit': '2.71', 'upperLimit': '2.95'}]}]}, {'title': 'These messages will motivate NON-USERS to start vaping.', 'categories': [{'measurements': [{'value': '1.26', 'groupId': 'OG000', 'lowerLimit': '1.20', 'upperLimit': '1.33'}, {'value': '1.91', 'groupId': 'OG001', 'lowerLimit': '1.80', 'upperLimit': '2.02'}, {'value': '1.87', 'groupId': 'OG002', 'lowerLimit': '1.75', 'upperLimit': '1.98'}, {'value': '1.62', 'groupId': 'OG003', 'lowerLimit': '1.53', 'upperLimit': '1.72'}, {'value': '2.17', 'groupId': 'OG004', 'lowerLimit': '2.05', 'upperLimit': '2.29'}, {'value': '2.14', 'groupId': 'OG005', 'lowerLimit': '2.02', 'upperLimit': '2.26'}, {'value': '1.26', 'groupId': 'OG006', 'lowerLimit': '1.20', 'upperLimit': '1.33'}]}]}, {'title': 'These messages will motivate NON-USERS to start smoking cigarettes.', 'categories': [{'measurements': [{'value': '1.24', 'groupId': 'OG000', 'lowerLimit': '1.17', 'upperLimit': '1.30'}, {'value': '1.29', 'groupId': 'OG001', 'lowerLimit': '1.22', 'upperLimit': '1.36'}, {'value': '1.35', 'groupId': 'OG002', 'lowerLimit': '1.27', 'upperLimit': '1.42'}, {'value': '1.21', 'groupId': 'OG003', 'lowerLimit': '1.15', 'upperLimit': '1.27'}, {'value': '1.30', 'groupId': 'OG004', 'lowerLimit': '1.23', 'upperLimit': '1.37'}, {'value': '1.32', 'groupId': 'OG005', 'lowerLimit': '1.25', 'upperLimit': '1.40'}, {'value': '1.24', 'groupId': 'OG006', 'lowerLimit': '1.18', 'upperLimit': '1.30'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Immediately post-exposure to intervention, up to 1 hour', 'description': 'Six items were analyzed separately, each scored on 5-point Likert scale (1=Strongly Disagree, 5=Strongly Agree)\n\nThese messages will motivate CIGARETTE SMOKERS to switch to vaping.\n\nThese messages will motivate people to quit ALL smoking and vaping.\n\nThese messages will motivate NON-USERS to start vaping.\n\nThese messages will motivate NON-USERS to start smoking cigarettes.\n\nThese messages will motivate CIGARETTE SMOKERS to quit.\n\nThese messages will motivate VAPERS to quit.', 'unitOfMeasure': 'units on a scale', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Analytic population did not include participants with missing data for outcomes.'}, {'type': 'PRIMARY', 'title': 'Risk Perceptions: Absolute/Relative Risks of Cigarette vs. E-cigarette Use', 'denoms': [{'units': 'Participants', 'counts': [{'value': '399', 'groupId': 'OG000'}, {'value': '402', 'groupId': 'OG001'}, {'value': '396', 'groupId': 'OG002'}, {'value': '403', 'groupId': 'OG003'}, {'value': '402', 'groupId': 'OG004'}, {'value': '402', 'groupId': 'OG005'}, {'value': '403', 'groupId': 'OG006'}]}], 'groups': [{'id': 'OG000', 'title': 'AR-Quit', 'description': 'Participants view messages with absolute risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG001', 'title': 'AR-Switch', 'description': 'Participants view messages with absolute risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG002', 'title': 'AR-Combination', 'description': 'Participants view messages with absolute risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG003', 'title': 'RR-Quit', 'description': 'Participants view messages with comparative risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG004', 'title': 'RR-Switch', 'description': 'Participants view messages with comparative risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG005', 'title': 'RR-Combination', 'description': 'Participants view messages with comparative risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG006', 'title': 'Control', 'description': 'Participants view FDA regulatory messages\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}], 'classes': [{'title': 'Absolute harm of cigarettes to health', 'categories': [{'measurements': [{'value': '9.08', 'groupId': 'OG000', 'lowerLimit': '8.95', 'upperLimit': '9.21'}, {'value': '9.07', 'groupId': 'OG001', 'lowerLimit': '8.93', 'upperLimit': '9.21'}, {'value': '8.97', 'groupId': 'OG002', 'lowerLimit': '8.82', 'upperLimit': '9.12'}, {'value': '9.11', 'groupId': 'OG003', 'lowerLimit': '8.98', 'upperLimit': '9.24'}, {'value': '9.06', 'groupId': 'OG004', 'lowerLimit': '8.93', 'upperLimit': '9.20'}, {'value': '9.04', 'groupId': 'OG005', 'lowerLimit': '8.89', 'upperLimit': '9.19'}, {'value': '8.94', 'groupId': 'OG006', 'lowerLimit': '8.79', 'upperLimit': '9.09'}]}]}, {'title': 'Absolute harm of nicotine vapes to health', 'categories': [{'measurements': [{'value': '7.57', 'groupId': 'OG000', 'lowerLimit': '7.35', 'upperLimit': '7.79'}, {'value': '7.05', 'groupId': 'OG001', 'lowerLimit': '6.83', 'upperLimit': '7.27'}, {'value': '7.19', 'groupId': 'OG002', 'lowerLimit': '6.96', 'upperLimit': '7.42'}, {'value': '7.19', 'groupId': 'OG003', 'lowerLimit': '6.97', 'upperLimit': '7.42'}, {'value': '6.88', 'groupId': 'OG004', 'lowerLimit': '6.64', 'upperLimit': '7.11'}, {'value': '6.94', 'groupId': 'OG005', 'lowerLimit': '6.71', 'upperLimit': '7.17'}, {'value': '7.57', 'groupId': 'OG006', 'lowerLimit': '7.34', 'upperLimit': '7.80'}]}]}, {'title': 'Relative harm of nicotine vapes (vs combustible cigarettes) to health', 'categories': [{'measurements': [{'value': '4.99', 'groupId': 'OG000', 'lowerLimit': '4.71', 'upperLimit': '5.26'}, {'value': '4.65', 'groupId': 'OG001', 'lowerLimit': '4.38', 'upperLimit': '4.92'}, {'value': '4.81', 'groupId': 'OG002', 'lowerLimit': '4.51', 'upperLimit': '5.11'}, {'value': '4.46', 'groupId': 'OG003', 'lowerLimit': '4.16', 'upperLimit': '4.75'}, {'value': '4.34', 'groupId': 'OG004', 'lowerLimit': '4.05', 'upperLimit': '4.64'}, {'value': '4.49', 'groupId': 'OG005', 'lowerLimit': '4.20', 'upperLimit': '4.78'}, {'value': '5.04', 'groupId': 'OG006', 'lowerLimit': '4.77', 'upperLimit': '5.30'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Immediately post-exposure to intervention, up to 1 hour', 'description': 'On a scale from 0-10, where 0 = not at all harmful and 10 = extremely harmful now harmful are ... to your health?\n\n* combustible cigarettes\n* nicotine vapes\n\nOn a scale from 0-10, where 0 = much less harmful and 10 = much more harmful...\n\n• compared to combustible cigarettes, how harmful are nicotine vapes to your health?', 'unitOfMeasure': 'units on a scale', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Analytic population included participants with no missing data on outcomes.'}, {'type': 'PRIMARY', 'title': 'Behavioral Intentions to Use Tobacco', 'denoms': [{'units': 'Participants', 'counts': [{'value': '403', 'groupId': 'OG000'}, {'value': '407', 'groupId': 'OG001'}, {'value': '399', 'groupId': 'OG002'}, {'value': '405', 'groupId': 'OG003'}, {'value': '403', 'groupId': 'OG004'}, {'value': '405', 'groupId': 'OG005'}, {'value': '405', 'groupId': 'OG006'}]}], 'groups': [{'id': 'OG000', 'title': 'AR-Quit', 'description': 'Participants view messages with absolute risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG001', 'title': 'AR-Switch', 'description': 'Participants view messages with absolute risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG002', 'title': 'AR-Combination', 'description': 'Participants view messages with absolute risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG003', 'title': 'RR-Quit', 'description': 'Participants view messages with comparative risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG004', 'title': 'RR-Switch', 'description': 'Participants view messages with comparative risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG005', 'title': 'RR-Combination', 'description': 'Participants view messages with comparative risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'OG006', 'title': 'Control', 'description': 'Participants view FDA regulatory messages\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}], 'classes': [{'title': 'Behavioral intentions to use nicotine vapes', 'categories': [{'measurements': [{'value': '3.27', 'groupId': 'OG000', 'lowerLimit': '3.17', 'upperLimit': '3.36'}, {'value': '3.16', 'groupId': 'OG001', 'lowerLimit': '3.06', 'upperLimit': '3.26'}, {'value': '3.16', 'groupId': 'OG002', 'lowerLimit': '3.06', 'upperLimit': '3.27'}, {'value': '3.22', 'groupId': 'OG003', 'lowerLimit': '3.12', 'upperLimit': '3.31'}, {'value': '3.11', 'groupId': 'OG004', 'lowerLimit': '3.01', 'upperLimit': '3.22'}, {'value': '3.17', 'groupId': 'OG005', 'lowerLimit': '3.07', 'upperLimit': '3.27'}, {'value': '3.15', 'groupId': 'OG006', 'lowerLimit': '3.04', 'upperLimit': '3.25'}]}]}, {'title': 'Behavioral intentions to smoke cigarettes', 'categories': [{'measurements': [{'value': '3.48', 'groupId': 'OG000', 'lowerLimit': '3.40', 'upperLimit': '3.56'}, {'value': '3.40', 'groupId': 'OG001', 'lowerLimit': '3.31', 'upperLimit': '3.49'}, {'value': '3.40', 'groupId': 'OG002', 'lowerLimit': '3.30', 'upperLimit': '3.49'}, {'value': '3.46', 'groupId': 'OG003', 'lowerLimit': '3.37', 'upperLimit': '3.54'}, {'value': '3.46', 'groupId': 'OG004', 'lowerLimit': '3.38', 'upperLimit': '3.55'}, {'value': '3.44', 'groupId': 'OG005', 'lowerLimit': '3.35', 'upperLimit': '3.52'}, {'value': '3.37', 'groupId': 'OG006', 'lowerLimit': '3.28', 'upperLimit': '3.46'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Immediately post-exposure to intervention, up to 1 hour', 'description': '8-items made up two 4-pt scales (1 = definitely will not and 4 = definitely will).\n\nItems for each scale were summed and averaged. Higher scores indicate higher likelihood of avoiding cigarettes/nicotine vapes.\n\nHow likely it is that in the next 3 months, you will refrain from...\n\n* smoking cigarettes completely and permanently?\n* smoking cigarettes when you get lonely?\n* smoking cigarettes when you are with your friends who use them?\n* smoking cigarettes when someone hands you a cigarette?\n\nHow likely it is that in the next 3 months, you will refrain from...\n\n* vaping nicotine completely and permanently?\n* vaping nicotine when you get lonely?\n* vaping nicotine when you are with your friends who use them?\n* vaping nicotine when someone hands you a vape?', 'unitOfMeasure': 'units on a scale', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Analytic population included participants who did not have missing data on outcomes.'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'AR-Quit', 'description': 'Participants view messages with absolute risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'FG001', 'title': 'AR-Switch', 'description': 'Participants view messages with absolute risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'FG002', 'title': 'AR-Combination', 'description': 'Participants view messages with absolute risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'FG003', 'title': 'RR-Quit', 'description': 'Participants view messages with comparative risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'FG004', 'title': 'RR-Switch', 'description': 'Participants view messages with comparative risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'FG005', 'title': 'RR-Combination', 'description': 'Participants view messages with comparative risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'FG006', 'title': 'Control', 'description': 'Participants view FDA regulatory messages\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '407'}, {'groupId': 'FG001', 'numSubjects': '407'}, {'groupId': 'FG002', 'numSubjects': '407'}, {'groupId': 'FG003', 'numSubjects': '407'}, {'groupId': 'FG004', 'numSubjects': '407'}, {'groupId': 'FG005', 'numSubjects': '407'}, {'groupId': 'FG006', 'numSubjects': '407'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '400'}, {'groupId': 'FG001', 'numSubjects': '405'}, {'groupId': 'FG002', 'numSubjects': '398'}, {'groupId': 'FG003', 'numSubjects': '404'}, {'groupId': 'FG004', 'numSubjects': '402'}, {'groupId': 'FG005', 'numSubjects': '403'}, {'groupId': 'FG006', 'numSubjects': '404'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '7'}, {'groupId': 'FG001', 'numSubjects': '2'}, {'groupId': 'FG002', 'numSubjects': '9'}, {'groupId': 'FG003', 'numSubjects': '3'}, {'groupId': 'FG004', 'numSubjects': '5'}, {'groupId': 'FG005', 'numSubjects': '4'}, {'groupId': 'FG006', 'numSubjects': '3'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '407', 'groupId': 'BG000'}, {'value': '407', 'groupId': 'BG001'}, {'value': '407', 'groupId': 'BG002'}, {'value': '407', 'groupId': 'BG003'}, {'value': '407', 'groupId': 'BG004'}, {'value': '407', 'groupId': 'BG005'}, {'value': '407', 'groupId': 'BG006'}, {'value': '2849', 'groupId': 'BG007'}]}], 'groups': [{'id': 'BG000', 'title': 'AR-Quit', 'description': 'Participants view messages with absolute risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'BG001', 'title': 'AR-Switch', 'description': 'Participants view messages with absolute risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'BG002', 'title': 'AR-Combination', 'description': 'Participants view messages with absolute risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'BG003', 'title': 'RR-Quit', 'description': 'Participants view messages with comparative risk and quit statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'BG004', 'title': 'RR-Switch', 'description': 'Participants view messages with comparative risk and switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'BG005', 'title': 'RR-Combination', 'description': 'Participants view messages with comparative risk and combination quit+switch statements\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'BG006', 'title': 'Control', 'description': 'Participants view FDA regulatory messages\n\nHealth communications: Participants are assigned to view health communications with risk and efficacy statements.'}, {'id': 'BG007', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Customized', 'classes': [{'title': '18-24 years old', 'categories': [{'measurements': [{'value': '131', 'groupId': 'BG000'}, {'value': '123', 'groupId': 'BG001'}, {'value': '138', 'groupId': 'BG002'}, {'value': '126', 'groupId': 'BG003'}, {'value': '133', 'groupId': 'BG004'}, {'value': '139', 'groupId': 'BG005'}, {'value': '138', 'groupId': 'BG006'}, {'value': '928', 'groupId': 'BG007'}]}]}, {'title': '25-35 years old', 'categories': [{'measurements': [{'value': '270', 'groupId': 'BG000'}, {'value': '283', 'groupId': 'BG001'}, {'value': '261', 'groupId': 'BG002'}, {'value': '278', 'groupId': 'BG003'}, {'value': '270', 'groupId': 'BG004'}, {'value': '265', 'groupId': 'BG005'}, {'value': '267', 'groupId': 'BG006'}, {'value': '1894', 'groupId': 'BG007'}]}]}, {'title': 'Unknown or not reported', 'categories': [{'measurements': [{'value': '6', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '3', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '27', 'groupId': 'BG007'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Sex/Gender, Customized', 'classes': [{'title': 'Cisgender female', 'categories': [{'measurements': [{'value': '195', 'groupId': 'BG000'}, {'value': '192', 'groupId': 'BG001'}, {'value': '195', 'groupId': 'BG002'}, {'value': '187', 'groupId': 'BG003'}, {'value': '224', 'groupId': 'BG004'}, {'value': '187', 'groupId': 'BG005'}, {'value': '185', 'groupId': 'BG006'}, {'value': '1365', 'groupId': 'BG007'}]}]}, {'title': 'Cisgender Male', 'categories': [{'measurements': [{'value': '169', 'groupId': 'BG000'}, {'value': '183', 'groupId': 'BG001'}, {'value': '163', 'groupId': 'BG002'}, {'value': '179', 'groupId': 'BG003'}, {'value': '152', 'groupId': 'BG004'}, {'value': '171', 'groupId': 'BG005'}, {'value': '180', 'groupId': 'BG006'}, {'value': '1197', 'groupId': 'BG007'}]}]}, {'title': 'Transgender or gender diverse', 'categories': [{'measurements': [{'value': '36', 'groupId': 'BG000'}, {'value': '30', 'groupId': 'BG001'}, {'value': '41', 'groupId': 'BG002'}, {'value': '38', 'groupId': 'BG003'}, {'value': '27', 'groupId': 'BG004'}, {'value': '46', 'groupId': 'BG005'}, {'value': '40', 'groupId': 'BG006'}, {'value': '258', 'groupId': 'BG007'}]}]}, {'title': 'Unknown or not reported', 'categories': [{'measurements': [{'value': '7', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '3', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '29', 'groupId': 'BG007'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Ethnicity (NIH/OMB)', 'classes': [{'categories': [{'title': 'Hispanic or Latino', 'measurements': [{'value': '58', 'groupId': 'BG000'}, {'value': '59', 'groupId': 'BG001'}, {'value': '49', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '45', 'groupId': 'BG004'}, {'value': '62', 'groupId': 'BG005'}, {'value': '48', 'groupId': 'BG006'}, {'value': '378', 'groupId': 'BG007'}]}, {'title': 'Not Hispanic or Latino', 'measurements': [{'value': '343', 'groupId': 'BG000'}, {'value': '347', 'groupId': 'BG001'}, {'value': '350', 'groupId': 'BG002'}, {'value': '347', 'groupId': 'BG003'}, {'value': '358', 'groupId': 'BG004'}, {'value': '342', 'groupId': 'BG005'}, {'value': '357', 'groupId': 'BG006'}, {'value': '2444', 'groupId': 'BG007'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '6', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '3', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '27', 'groupId': 'BG007'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race (NIH/OMB)', 'classes': [{'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '22', 'groupId': 'BG007'}]}, {'title': 'Asian', 'measurements': [{'value': '30', 'groupId': 'BG000'}, {'value': '39', 'groupId': 'BG001'}, {'value': '28', 'groupId': 'BG002'}, {'value': '43', 'groupId': 'BG003'}, {'value': '31', 'groupId': 'BG004'}, {'value': '36', 'groupId': 'BG005'}, {'value': '31', 'groupId': 'BG006'}, {'value': '238', 'groupId': 'BG007'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '2', 'groupId': 'BG006'}, {'value': '5', 'groupId': 'BG007'}]}, {'title': 'Black or African American', 'measurements': [{'value': '47', 'groupId': 'BG000'}, {'value': '41', 'groupId': 'BG001'}, {'value': '45', 'groupId': 'BG002'}, {'value': '39', 'groupId': 'BG003'}, {'value': '42', 'groupId': 'BG004'}, {'value': '55', 'groupId': 'BG005'}, {'value': '53', 'groupId': 'BG006'}, {'value': '322', 'groupId': 'BG007'}]}, {'title': 'White', 'measurements': [{'value': '253', 'groupId': 'BG000'}, {'value': '256', 'groupId': 'BG001'}, {'value': '258', 'groupId': 'BG002'}, {'value': '246', 'groupId': 'BG003'}, {'value': '266', 'groupId': 'BG004'}, {'value': '244', 'groupId': 'BG005'}, {'value': '264', 'groupId': 'BG006'}, {'value': '1787', 'groupId': 'BG007'}]}, {'title': 'More than one race', 'measurements': [{'value': '24', 'groupId': 'BG000'}, {'value': '24', 'groupId': 'BG001'}, {'value': '29', 'groupId': 'BG002'}, {'value': '32', 'groupId': 'BG003'}, {'value': '32', 'groupId': 'BG004'}, {'value': '27', 'groupId': 'BG005'}, {'value': '16', 'groupId': 'BG006'}, {'value': '184', 'groupId': 'BG007'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '50', 'groupId': 'BG000'}, {'value': '45', 'groupId': 'BG001'}, {'value': '42', 'groupId': 'BG002'}, {'value': '43', 'groupId': 'BG003'}, {'value': '31', 'groupId': 'BG004'}, {'value': '41', 'groupId': 'BG005'}, {'value': '39', 'groupId': 'BG006'}, {'value': '291', 'groupId': 'BG007'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'United States', 'categories': [{'measurements': [{'value': '407', 'groupId': 'BG000'}, {'value': '407', 'groupId': 'BG001'}, {'value': '407', 'groupId': 'BG002'}, {'value': '407', 'groupId': 'BG003'}, {'value': '407', 'groupId': 'BG004'}, {'value': '407', 'groupId': 'BG005'}, {'value': '407', 'groupId': 'BG006'}, {'value': '2849', 'groupId': 'BG007'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}, {'title': 'Sexual Orientation', 'classes': [{'title': 'Heterosexual', 'categories': [{'measurements': [{'value': '206', 'groupId': 'BG000'}, {'value': '225', 'groupId': 'BG001'}, {'value': '200', 'groupId': 'BG002'}, {'value': '215', 'groupId': 'BG003'}, {'value': '215', 'groupId': 'BG004'}, {'value': '220', 'groupId': 'BG005'}, {'value': '212', 'groupId': 'BG006'}, {'value': '1493', 'groupId': 'BG007'}]}]}, {'title': 'Lesbian or gay', 'categories': [{'measurements': [{'value': '46', 'groupId': 'BG000'}, {'value': '43', 'groupId': 'BG001'}, {'value': '38', 'groupId': 'BG002'}, {'value': '45', 'groupId': 'BG003'}, {'value': '37', 'groupId': 'BG004'}, {'value': '46', 'groupId': 'BG005'}, {'value': '44', 'groupId': 'BG006'}, {'value': '299', 'groupId': 'BG007'}]}]}, {'title': 'Bisexual', 'categories': [{'measurements': [{'value': '129', 'groupId': 'BG000'}, {'value': '121', 'groupId': 'BG001'}, {'value': '131', 'groupId': 'BG002'}, {'value': '126', 'groupId': 'BG003'}, {'value': '141', 'groupId': 'BG004'}, {'value': '124', 'groupId': 'BG005'}, {'value': '133', 'groupId': 'BG006'}, {'value': '905', 'groupId': 'BG007'}]}]}, {'title': 'Ace/Asexual', 'categories': [{'measurements': [{'value': '19', 'groupId': 'BG000'}, {'value': '17', 'groupId': 'BG001'}, {'value': '29', 'groupId': 'BG002'}, {'value': '16', 'groupId': 'BG003'}, {'value': '10', 'groupId': 'BG004'}, {'value': '13', 'groupId': 'BG005'}, {'value': '14', 'groupId': 'BG006'}, {'value': '118', 'groupId': 'BG007'}]}]}, {'title': 'Unknown or not reported', 'categories': [{'measurements': [{'value': '7', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '9', 'groupId': 'BG002'}, {'value': '5', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '4', 'groupId': 'BG006'}, {'value': '34', 'groupId': 'BG007'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Smoking status', 'classes': [{'title': 'Currently use cigarettes', 'categories': [{'measurements': [{'value': '108', 'groupId': 'BG000'}, {'value': '114', 'groupId': 'BG001'}, {'value': '106', 'groupId': 'BG002'}, {'value': '106', 'groupId': 'BG003'}, {'value': '93', 'groupId': 'BG004'}, {'value': '106', 'groupId': 'BG005'}, {'value': '117', 'groupId': 'BG006'}, {'value': '750', 'groupId': 'BG007'}]}]}, {'title': 'Formerly used cigarettes', 'categories': [{'measurements': [{'value': '168', 'groupId': 'BG000'}, {'value': '148', 'groupId': 'BG001'}, {'value': '176', 'groupId': 'BG002'}, {'value': '170', 'groupId': 'BG003'}, {'value': '192', 'groupId': 'BG004'}, {'value': '171', 'groupId': 'BG005'}, {'value': '159', 'groupId': 'BG006'}, {'value': '1184', 'groupId': 'BG007'}]}]}, {'title': 'Never used cigarettes', 'categories': [{'measurements': [{'value': '131', 'groupId': 'BG000'}, {'value': '145', 'groupId': 'BG001'}, {'value': '125', 'groupId': 'BG002'}, {'value': '131', 'groupId': 'BG003'}, {'value': '122', 'groupId': 'BG004'}, {'value': '130', 'groupId': 'BG005'}, {'value': '131', 'groupId': 'BG006'}, {'value': '915', 'groupId': 'BG007'}]}]}, {'title': 'Unknown or not reported', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Participants self-identified as currently using combustible cigarettes (use within the past 30-days), formerly using cigarettes (used at least once in lifetime, but not within past 30-days), and never using cigarettes.', 'unitOfMeasure': 'Participants'}, {'title': 'Vaping status', 'classes': [{'title': 'Currently vape nicotine', 'categories': [{'measurements': [{'value': '141', 'groupId': 'BG000'}, {'value': '144', 'groupId': 'BG001'}, {'value': '146', 'groupId': 'BG002'}, {'value': '137', 'groupId': 'BG003'}, {'value': '160', 'groupId': 'BG004'}, {'value': '147', 'groupId': 'BG005'}, {'value': '140', 'groupId': 'BG006'}, {'value': '1015', 'groupId': 'BG007'}]}]}, {'title': 'Formerly vaped nicotine', 'categories': [{'measurements': [{'value': '139', 'groupId': 'BG000'}, {'value': '133', 'groupId': 'BG001'}, {'value': '132', 'groupId': 'BG002'}, {'value': '141', 'groupId': 'BG003'}, {'value': '118', 'groupId': 'BG004'}, {'value': '117', 'groupId': 'BG005'}, {'value': '135', 'groupId': 'BG006'}, {'value': '915', 'groupId': 'BG007'}]}]}, {'title': 'Never vaped nicotine', 'categories': [{'measurements': [{'value': '127', 'groupId': 'BG000'}, {'value': '130', 'groupId': 'BG001'}, {'value': '129', 'groupId': 'BG002'}, {'value': '129', 'groupId': 'BG003'}, {'value': '129', 'groupId': 'BG004'}, {'value': '143', 'groupId': 'BG005'}, {'value': '132', 'groupId': 'BG006'}, {'value': '919', 'groupId': 'BG007'}]}]}, {'title': 'Unknown or not reported', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Participants self-identified as currently using nicotine vapes (use within the past 30-days), formerly using nicotine vapes (used at least once in lifetime, but not within past 30-days), and never using nicotine vapes.', 'unitOfMeasure': 'Participants'}, {'title': 'Dual smoking/vaping status', 'classes': [{'title': 'Currently vape nicotine AND smoke cigarettes', 'categories': [{'measurements': [{'value': '63', 'groupId': 'BG000'}, {'value': '73', 'groupId': 'BG001'}, {'value': '65', 'groupId': 'BG002'}, {'value': '57', 'groupId': 'BG003'}, {'value': '61', 'groupId': 'BG004'}, {'value': '64', 'groupId': 'BG005'}, {'value': '69', 'groupId': 'BG006'}, {'value': '452', 'groupId': 'BG007'}]}]}, {'title': 'Formerly vaped nicotine AND smoked cigarettes', 'categories': [{'measurements': [{'value': '177', 'groupId': 'BG000'}, {'value': '162', 'groupId': 'BG001'}, {'value': '176', 'groupId': 'BG002'}, {'value': '177', 'groupId': 'BG003'}, {'value': '184', 'groupId': 'BG004'}, {'value': '169', 'groupId': 'BG005'}, {'value': '168', 'groupId': 'BG006'}, {'value': '1213', 'groupId': 'BG007'}]}]}, {'title': 'Only ever vaped nicotine OR smoked cigarettes', 'categories': [{'measurements': [{'value': '76', 'groupId': 'BG000'}, {'value': '69', 'groupId': 'BG001'}, {'value': '78', 'groupId': 'BG002'}, {'value': '86', 'groupId': 'BG003'}, {'value': '73', 'groupId': 'BG004'}, {'value': '75', 'groupId': 'BG005'}, {'value': '77', 'groupId': 'BG006'}, {'value': '534', 'groupId': 'BG007'}]}]}, {'title': 'Never vaped nicotine OR smoked cigarettes', 'categories': [{'measurements': [{'value': '91', 'groupId': 'BG000'}, {'value': '103', 'groupId': 'BG001'}, {'value': '88', 'groupId': 'BG002'}, {'value': '87', 'groupId': 'BG003'}, {'value': '89', 'groupId': 'BG004'}, {'value': '99', 'groupId': 'BG005'}, {'value': '93', 'groupId': 'BG006'}, {'value': '650', 'groupId': 'BG007'}]}]}, {'title': 'Unknown or not reported', 'categories': [{'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Participants self-identified as currently using both combustible cigarettes and nicotine vapes (use within the past 30-days), formerly using both cigarettes and nicotine vapes (used at least once in lifetime, but not within past 30-days), currently using cigarettes OR nicotine vapes (not both), or never using either cigarettes or nicotine vapes.', 'unitOfMeasure': 'Participants'}]}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2022-07-22', 'size': 476961, 'label': 'Study Protocol and Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'Prot_SAP_000.pdf', 'typeAbbrev': 'Prot_SAP', 'uploadDate': '2023-11-13T20:44', 'hasProtocol': True}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}, 'primaryPurpose': 'PREVENTION', 'interventionModel': 'FACTORIAL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 2849}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-04-14', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-12', 'completionDateStruct': {'date': '2022-11-14', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2023-12-05', 'studyFirstSubmitDate': '2022-05-18', 'resultsFirstSubmitDate': '2023-11-13', 'studyFirstSubmitQcDate': '2022-05-23', 'lastUpdatePostDateStruct': {'date': '2023-12-26', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2023-12-05', 'studyFirstPostDateStruct': {'date': '2022-05-26', 'type': 'ACTUAL'}, 'resultsFirstPostDateStruct': {'date': '2023-12-26', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2022-11-14', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Message Perceived Effectiveness - Persuasive Potential.', 'timeFrame': 'Immediately post-exposure to intervention, up to 1 hour', 'description': '6 items measured on 5-point scale, 1 = Not at all and 5 = Very much\n\n* These messages were worth remembering.\n* These messages grabbed my attention.\n* These messages are powerful.\n* These messages are convincing.\n* These messages are meaningful.\n* These messages are informative.\n\nResponses were summed and averaged to create a scale for intention to quit (range from 1 - 5).\n\nHigher scores indicate a higher persuasive potential of the message.'}, {'measure': 'Perceived Effectiveness - Perceived Behavioral Impact', 'timeFrame': 'Immediately post-exposure to intervention, up to 1 hour', 'description': 'Six items were analyzed separately, each scored on 5-point Likert scale (1=Strongly Disagree, 5=Strongly Agree)\n\nThese messages will motivate CIGARETTE SMOKERS to switch to vaping.\n\nThese messages will motivate people to quit ALL smoking and vaping.\n\nThese messages will motivate NON-USERS to start vaping.\n\nThese messages will motivate NON-USERS to start smoking cigarettes.\n\nThese messages will motivate CIGARETTE SMOKERS to quit.\n\nThese messages will motivate VAPERS to quit.'}, {'measure': 'Risk Perceptions: Absolute/Relative Risks of Cigarette vs. E-cigarette Use', 'timeFrame': 'Immediately post-exposure to intervention, up to 1 hour', 'description': 'On a scale from 0-10, where 0 = not at all harmful and 10 = extremely harmful now harmful are ... to your health?\n\n* combustible cigarettes\n* nicotine vapes\n\nOn a scale from 0-10, where 0 = much less harmful and 10 = much more harmful...\n\n• compared to combustible cigarettes, how harmful are nicotine vapes to your health?'}, {'measure': 'Behavioral Intentions to Use Tobacco', 'timeFrame': 'Immediately post-exposure to intervention, up to 1 hour', 'description': '8-items made up two 4-pt scales (1 = definitely will not and 4 = definitely will).\n\nItems for each scale were summed and averaged. Higher scores indicate higher likelihood of avoiding cigarettes/nicotine vapes.\n\nHow likely it is that in the next 3 months, you will refrain from...\n\n* smoking cigarettes completely and permanently?\n* smoking cigarettes when you get lonely?\n* smoking cigarettes when you are with your friends who use them?\n* smoking cigarettes when someone hands you a cigarette?\n\nHow likely it is that in the next 3 months, you will refrain from...\n\n* vaping nicotine completely and permanently?\n* vaping nicotine when you get lonely?\n* vaping nicotine when you are with your friends who use them?\n* vaping nicotine when someone hands you a vape?'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Tobacco-Related Carcinoma']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'http://cancer.osu.edu', 'label': 'The Jamesline'}]}, 'descriptionModule': {'briefSummary': 'This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportionately high among LGBT young adults. This trial seeks to determine effective communication of polytobacco use risk to at-risk LGBT young adults.', 'detailedDescription': 'PRIMARY OBJECTIVES:\n\nI. Identify absolute and relative risk anti-tobacco messages that effectively communicate polytobacco risks to lesbian, gay, bisexual, transgender (LGBT) young adults.\n\nParticipants view anti-tobacco messages and rate them for perceived effectiveness and reactance.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '35 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Young adults (age 18-35 years)\n* Live in the United States\n\nAt least 50% of the sample also:\n\n* Are susceptible to multiple nicotine and tobacco product use (i.e., have used combustible tobacco or e-cigarettes at least once)'}, 'identificationModule': {'nctId': 'NCT05393869', 'briefTitle': 'Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults', 'organization': {'class': 'OTHER', 'fullName': 'Ohio State University Comprehensive Cancer Center'}, 'officialTitle': 'The Effect of Nicotine and Tobacco Message Framing on Use Among Diverse Groups of Young Adults', 'orgStudyIdInfo': {'id': 'OSU-20427'}, 'secondaryIdInfos': [{'id': 'NCI-2022-02543', 'type': 'REGISTRY', 'domain': 'CTRP (Clinical Trial Reporting Program)'}, {'id': 'K99CA260718', 'link': 'https://reporter.nih.gov/quickSearch/K99CA260718', 'type': 'NIH'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'AR-Quit', 'description': 'Participants view messages with absolute risk and quit statements', 'interventionNames': ['Other: Health communications']}, {'type': 'EXPERIMENTAL', 'label': 'AR-Switch', 'description': 'Participants view messages with absolute risk and switch statements', 'interventionNames': ['Other: Health communications']}, {'type': 'EXPERIMENTAL', 'label': 'AR-Combination', 'description': 'Participants view messages with absolute risk and combination quit+switch statements', 'interventionNames': ['Other: Health communications']}, {'type': 'EXPERIMENTAL', 'label': 'RR-Quit', 'description': 'Participants view messages with comparative risk and quit statements', 'interventionNames': ['Other: Health communications']}, {'type': 'EXPERIMENTAL', 'label': 'RR-Switch', 'description': 'Participants view messages with comparative risk and switch statements', 'interventionNames': ['Other: Health communications']}, {'type': 'EXPERIMENTAL', 'label': 'RR-Combination', 'description': 'Participants view messages with comparative risk and combination quit+switch statements', 'interventionNames': ['Other: Health communications']}, {'type': 'OTHER', 'label': 'Control', 'description': 'Participants view FDA regulatory messages', 'interventionNames': ['Other: Health communications']}], 'interventions': [{'name': 'Health communications', 'type': 'OTHER', 'description': 'Participants are assigned to view health communications with risk and efficacy statements.', 'armGroupLabels': ['AR-Combination', 'AR-Quit', 'AR-Switch', 'Control', 'RR-Combination', 'RR-Quit', 'RR-Switch']}]}, 'contactsLocationsModule': {'locations': [{'zip': '43210', 'city': 'Columbus', 'state': 'Ohio', 'country': 'United States', 'facility': 'Ohio State University Comprehensive Cancer Center', 'geoPoint': {'lat': 39.96118, 'lon': -82.99879}}], 'overallOfficials': [{'name': 'Joanne G Patterson, PhD MPH MSW', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Ohio State University Comprehensive Cancer Center'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Ohio State University Comprehensive Cancer Center', 'class': 'OTHER'}, 'collaborators': [{'name': 'National Cancer Institute (NCI)', 'class': 'NIH'}], 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': 'Joanne Patterson', 'investigatorAffiliation': 'Ohio State University Comprehensive Cancer Center'}}}}